Optimal Response in a Patient With CML Expressing BCR–ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report

Background/Aim: The Philadelphia chromosome is considered the hallmark of chronic myeloid leukemia (CML). However, although most patients with CML are diagnosed with the e13a2 or e14a2 breakpoint cluster region (BCR)–Abelson 1 (ABL1) fusion transcripts, about 5% of them carry rare BCR–ABL1 fusion tr...

全面介紹

Na minha lista:
書目詳細資料
發表在:In Vivo
Main Authors: MANZELLA, LIVIA, TIRRÒ, ELENA, VITALE, SILVIA RITA, PUMA, ADRIANA, CONSOLI, MARIA LETIZIA, TAMBÈ, LOREDANA, PENNISI, MARIA STELLA, DI GREGORIO, SANDRA, ROMANO, CHIARA, TOMARCHIO, CRISTINA, DI RAIMONDO, FRANCESCO, STAGNO, FABIO
格式: Artigo
語言:Inglês
出版: International Institute of Anticancer Research 2020
主題:
Research Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279803/
https://ncbi.nlm.nih.gov/pubmed/32354950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11933
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍